Dr. Ibrahim Aldoss, MD
Claim this profileCity of Hope Medical Center
Area of expertise
Acute Lymphoblastic Leukemia
Ibrahim Aldoss, MD has run 8 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Burkitt Lymphoma
Ibrahim Aldoss, MD has run 7 trials for Burkitt Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope Comprehensive Cancer Center
Clinical Trials Ibrahim Aldoss, MD is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
Venetoclax + Azacitidine
for Acute Myeloid Leukemia
This research is being done to assess the therapeutic activity of a promising combination (azacitidine and venetoclax) versus conventional cytotoxic chemotherapy in induction-eligible patients with acute myeloid leukemia. This study involves the following: * Venetoclax and azacitidine (investigational combination) * Cytarabine and idarubicin or daunorubicin (per standard of care) or Liposomal daunorubicin and cytarabine (per standard of care)
Recruiting
1 award
Phase 2
4 criteria
More about Ibrahim Aldoss, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Ibrahim Aldoss, MD has experience with
- CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
- Flotetuzumab
- Venetoclax
- Dexamethasone
- Cyclophosphamide
- Blinatumomab
Breakdown of trials Ibrahim Aldoss, MD has run
Acute Lymphoblastic Leukemia
Burkitt Lymphoma
Leukemia
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ibrahim Aldoss, MD specialize in?
Ibrahim Aldoss, MD focuses on Acute Lymphoblastic Leukemia and Burkitt Lymphoma. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD19 positive patients, or patients who are CAR T cells positive.
Is Ibrahim Aldoss, MD currently recruiting for clinical trials?
Yes, Ibrahim Aldoss, MD is currently recruiting for 8 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Ibrahim Aldoss, MD has studied deeply?
Yes, Ibrahim Aldoss, MD has studied treatments such as CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes, Flotetuzumab, Venetoclax.
What is the best way to schedule an appointment with Ibrahim Aldoss, MD?
Apply for one of the trials that Ibrahim Aldoss, MD is conducting.
What is the office address of Ibrahim Aldoss, MD?
The office of Ibrahim Aldoss, MD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.